SCHEMBL5587994

SCHEMBL5587994

CCCCCCCCCCc1cc(O)c(O)c(C(=O)O)c1OC

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BID P55957 3/20 0.52
MCL1 Q07820 3/20 0.52
PPARA Q07869 3/20 0.52
BCL2L1 Q07817 2/20 0.52
BAK1 Q16611 2/20 0.52
KAT8 Q9H7Z6 2/20 0.52
PPARG P37231 2/20 0.52
EP300 Q09472 1/20 0.52
KAT2A Q92830 1/20 0.52
KAT2B Q92831 1/20 0.52
KAT5 Q92993 1/20 0.52
SAE1 Q9UBE0 1/20 0.52
PTGES O14684 2/20 0.52
ALOX5 P09917 9/20 0.51
PPARD Q03181 1/20 0.49
TOP2A P11388 1/20 0.47
PTGS2 P35354 3/20 0.47
PTPN1 P18031 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5586822 1.00 BID (0.52) BIDMCL1PPARABCL2L1BAK1
SCHEMBL5590194 1.00 BID (0.52) BIDMCL1PPARABCL2L1BAK1
SCHEMBL5590509 1.00 BID (0.52) BIDMCL1PPARABCL2L1BAK1
SCHEMBL5590069 1.00 BID (0.52) BIDMCL1PPARABCL2L1BAK1
SCHEMBL5590550 0.99 PTGES (0.53) BIDMCL1PPARABCL2L1BAK1
SCHEMBL5587455 0.94 PTGES (0.48) BIDMCL1PPARABCL2L1BAK1
SCHEMBL5587709 0.88 PTPN1 (0.51) PPARAPPARGPTGESALOX5PPARD
SCHEMBL5590063 0.88 BID (0.51) BIDMCL1PPARABCL2L1BAK1
SCHEMBL5589517 0.88 BID (0.51) BIDMCL1PPARABCL2L1BAK1
SCHEMBL5590009 0.88 BID (0.51) BIDMCL1PPARABCL2L1BAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 BID 1517/4885MCL1 1660/4885PPARA 2921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.